Adastra Holdings Ltd. (XTXXF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Adastra Holdings Ltd. (XTXXF) with AI Score 45/100 (Weak). Adastra Holdings Ltd. specializes in cannabis extraction and processing solutions, catering to licensed cultivators and B2B partners. Sector: Healthcare.
Last analyzed: Mar 17, 2026XTXXF: the 1 perspectives are evenly split.
Adastra Holdings Ltd. (XTXXF) Healthcare & Pipeline Overview
Adastra Holdings Ltd. provides cannabis extraction and processing solutions, including analytical testing and supplying cannabis extracts to licensed cultivators and B2B partners. Operating in the specialty and generic drug manufacturing sector, the company focuses on the Canadian and international cannabis markets, facing competition and regulatory challenges.
What Is the Investment Thesis for XTXXF?
Adastra Holdings Ltd. operates in the evolving cannabis extraction and processing sector, presenting both opportunities and challenges. With a negative P/E ratio of -0.08 and a negative profit margin of -85.9%, the company's current financial performance raises concerns about its profitability. However, a gross margin of 32.3% indicates potential in its core operations if costs are managed effectively. Key value drivers include expanding its analytical testing and processing services to meet the growing demand from licensed cannabis cultivators. Growth catalysts involve securing additional B2B partnerships in both Canadian and international markets. Potential risks include navigating regulatory changes, managing competition from companies like ACUS and ADVT, and addressing its current financial losses to achieve sustainable profitability.
Based on FMP financials and quantitative analysis
XTXXF Key Highlights
- Market Cap of $0.00B reflects the company's small size and potential for growth or volatility.
- P/E Ratio of -0.08 indicates that the company is currently not profitable.
- Profit Margin of -85.9% highlights significant challenges in achieving profitability.
- Gross Margin of 32.3% suggests potential in core operations if costs are managed effectively.
- Beta of -0.49 indicates that the stock is less volatile than the market.
Who Are XTXXF's Competitors?
What Are XTXXF's Key Strengths?
- Established presence in the Canadian cannabis market.
- Comprehensive cannabis extraction and processing solutions.
- Analytical testing capabilities ensure product quality.
- Focus on B2B partnerships for distribution.
What Are XTXXF's Weaknesses?
- Negative profit margin indicates financial challenges.
- Small market capitalization limits access to capital.
- Dependence on regulatory environment in Canada.
- Limited brand recognition compared to larger competitors.
What Could Drive XTXXF Stock Higher?
- Expansion of cannabis extraction and processing capabilities.
- Securing strategic partnerships in international markets.
- Potential regulatory changes in the cannabis industry.
- Development of new and innovative cannabis extracts.
- Optimization of processing efficiency to reduce costs.
What Are the Key Risks for XTXXF?
- Intense competition from larger cannabis companies.
- Fluctuations in cannabis prices.
- Supply chain disruptions.
- Negative profit margin indicates financial challenges.
- Changes in regulatory landscape.
What Are the Growth Opportunities for XTXXF?
- Expansion of Analytical Testing Services: Adastra can capitalize on the increasing demand for cannabis analytical testing services. As regulatory requirements become more stringent, cultivators need reliable testing to ensure product quality and compliance. By expanding its testing capabilities and securing certifications, Adastra can attract more clients and increase its revenue. The market for cannabis testing is projected to grow as the industry matures, presenting a significant opportunity for Adastra.
- Strategic Partnerships in International Markets: Adastra can pursue strategic partnerships with international businesses to expand its market reach. By collaborating with established players in other countries, Adastra can gain access to new markets and distribution channels. This expansion can drive revenue growth and diversify its customer base. The global cannabis market is expanding rapidly, and strategic partnerships can provide Adastra with a competitive edge.
- Development of New Cannabis Extracts: Adastra can invest in research and development to create new and innovative cannabis extracts. By diversifying its product portfolio, Adastra can cater to different consumer preferences and market demands. This innovation can drive revenue growth and differentiate Adastra from its competitors. The market for cannabis extracts is constantly evolving, and new products can attract new customers.
- Optimization of Processing Efficiency: Adastra can focus on optimizing its processing efficiency to reduce costs and improve profitability. By implementing advanced technologies and streamlining its operations, Adastra can increase its gross margin and improve its financial performance. This optimization can make Adastra more competitive and attractive to investors. Efficient processing is crucial for success in the cannabis extraction industry.
- Compliance and Regulatory Expertise: Adastra can leverage its expertise in compliance and regulatory matters to provide value-added services to its clients. By helping cultivators navigate the complex regulatory landscape, Adastra can build strong relationships and secure long-term contracts. This expertise can differentiate Adastra from its competitors and establish it as a trusted partner in the cannabis industry. Regulatory compliance is a critical aspect of the cannabis market.
What Opportunities Does XTXXF Have?
- Expansion into international markets.
- Development of new and innovative cannabis extracts.
- Strategic partnerships with established players.
- Increased demand for cannabis analytical testing services.
What Threats Does XTXXF Face?
- Intense competition from larger cannabis companies.
- Changing regulatory landscape.
- Fluctuations in cannabis prices.
- Potential for supply chain disruptions.
What Are XTXXF's Competitive Advantages?
- Established relationships with licensed cultivators.
- Expertise in cannabis extraction and processing.
- Analytical testing capabilities ensure product quality.
- Strategic focus on B2B partnerships.
What Does XTXXF Do?
Adastra Holdings Ltd., formerly known as Phyto Extractions Inc., was incorporated in 1987 and rebranded in September 2021 to reflect its evolving focus on cannabis extraction and processing. Based in Langley, Canada, Adastra provides comprehensive solutions to licensed cannabis and hemp cultivators. Its core offerings include cannabis analytical testing, ensuring product quality and compliance, and cannabis processing services, which transform raw cannabis into various extracts. These extracts are then supplied to qualified business-to-business partners both within Canada and internationally. The company's services are crucial for cultivators seeking to optimize their yields and meet stringent regulatory requirements. By offering analytical testing, Adastra helps cultivators ensure their products meet quality standards and comply with health and safety regulations. The processing services enable cultivators to create a diverse range of cannabis extracts, catering to different market demands and consumer preferences. Adastra's strategic focus on B2B partnerships allows it to efficiently distribute its cannabis extracts to a wider network of qualified businesses, expanding its market reach and revenue streams. The company's long history, dating back to 1987, provides a foundation of experience in the extraction and processing industry, positioning it as a reliable partner in the rapidly growing cannabis market.
What Products and Services Does XTXXF Offer?
- Provides cannabis extraction services to licensed cultivators.
- Offers cannabis processing solutions.
- Supplies cannabis extracts to B2B partners.
- Conducts cannabis analytical testing.
- Helps cultivators meet regulatory requirements.
- Transforms raw cannabis into various extracts.
How Does XTXXF Make Money?
- Generates revenue through cannabis extraction and processing fees.
- Sells cannabis extracts to qualified B2B partners.
- Provides analytical testing services for cannabis products.
- Focuses on serving licensed cultivators of cannabis and hemp.
What Industry Does XTXXF Operate In?
Adastra Holdings Ltd. operates within the rapidly evolving cannabis industry, specifically in the extraction and processing segment. The market is characterized by increasing demand for cannabis extracts, driven by both medical and recreational use. Companies like ACUS, ADVT, BBBT, CANL, and NEPTF represent the competitive landscape. The industry faces ongoing regulatory changes and varying legal frameworks across different regions. Adastra's success depends on its ability to adapt to these changes, maintain product quality, and secure strategic partnerships to expand its market reach.
Who Are XTXXF's Key Customers?
- Licensed cannabis cultivators.
- Licensed hemp cultivators.
- Qualified Canadian B2B partners.
- Qualified International B2B partners.
XTXXF Financials
XTXXF Latest News
-
Adastra Holdings Announces Agreement to Sell Assets and Resignation of Director
newsfilecorp.com · Mar 2, 2026
XTXXF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for XTXXF.
Price Targets
Wall Street price target analysis for XTXXF.
XTXXF MoonshotScore
What does this score mean?
The MoonshotScore rates XTXXF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Brian O'Neill
CEO
Brian O'Neill is the Chief Executive Officer of Adastra Holdings Ltd. His background includes extensive experience in the cannabis industry, with a focus on extraction, processing, and regulatory compliance. He has a proven track record of leading companies through periods of growth and transformation. O'Neill's expertise encompasses strategic planning, operational management, and business development. He is committed to driving innovation and creating value for shareholders.
Track Record: Under Brian O'Neill's leadership, Adastra Holdings Ltd. has focused on expanding its cannabis extraction and processing capabilities. He has overseen the company's efforts to secure strategic partnerships and expand its market reach. O'Neill has also prioritized compliance with regulatory requirements and the development of high-quality cannabis extracts. His leadership has been instrumental in positioning Adastra as a key player in the Canadian cannabis market.
XTXXF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Adastra Holdings Ltd. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting and may not be subject to the same level of regulatory scrutiny as those listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases information asymmetry.
- Lower trading volumes can lead to price volatility.
- Wider bid-ask spreads can increase transaction costs.
- Potential for delisting or suspension from the OTC market.
- Higher risk of fraud or manipulation compared to major exchanges.
- Verify the company's financial statements and SEC filings (if available).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's compliance with regulatory requirements.
- Monitor trading volumes and price movements for unusual activity.
- Consult with a financial advisor before investing.
- Understand the risks associated with investing in OTC stocks.
- Company has been in operation since 1987.
- Focuses on cannabis extraction and processing, a growing market segment.
- Provides services to licensed cultivators, indicating regulatory compliance.
- Supplies cannabis extracts to B2B partners, suggesting established relationships.
- Operates in the healthcare sector, which is subject to regulatory oversight.
XTXXF Healthcare Stock FAQ
What does Adastra Holdings Ltd. do?
Adastra Holdings Ltd. operates as a cannabis extraction and processing solutions company, providing services to licensed cultivators of cannabis and hemp. The company offers cannabis analytical testing to ensure product quality and compliance, as well as cannabis processing services to transform raw cannabis into various extracts. These extracts are then supplied to qualified business-to-business partners in both Canadian and international markets, facilitating the distribution of cannabis products.
What do analysts say about XTXXF stock?
Currently, there is no available analyst consensus on XTXXF stock. Investors should conduct their own due diligence and consider the company's financial performance, market position, and growth opportunities. Key valuation metrics to consider include the company's market capitalization, P/E ratio, profit margin, and gross margin. Growth considerations include the company's ability to expand its services, secure strategic partnerships, and navigate the evolving regulatory landscape.
What are the main risks for XTXXF?
The main risks for Adastra Holdings Ltd. include intense competition from larger cannabis companies, fluctuations in cannabis prices, and potential supply chain disruptions. The company's negative profit margin indicates financial challenges, and changes in the regulatory landscape could impact its operations. As an OTC stock, XTXXF also faces risks associated with limited financial disclosure, lower trading volumes, and wider bid-ask spreads.
What are the key factors to evaluate for XTXXF?
Adastra Holdings Ltd. (XTXXF) currently holds an AI score of 45/100, indicating low score. Key strength: Established presence in the Canadian cannabis market. Primary risk to monitor: Intense competition from larger cannabis companies. This is not financial advice.
How frequently does XTXXF data refresh on this page?
XTXXF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven XTXXF's recent stock price performance?
Recent price movement in Adastra Holdings Ltd. (XTXXF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established presence in the Canadian cannabis market. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider XTXXF overvalued or undervalued right now?
Determining whether Adastra Holdings Ltd. (XTXXF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying XTXXF?
Before investing in Adastra Holdings Ltd. (XTXXF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited and may not be fully up-to-date.
- OTC market carries higher risks than major exchanges.
- Analyst coverage is limited for this stock.